Sorafenib and 5-Azacitidine in Acute Leukemia + Myelodysplastic Syndrome
Clinical trial NCT01254890 · COMPLETED
Trial details
- NCT number
- NCT01254890
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2015-03-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.